Extract from the Register of European Patents

EP About this file: EP2539439

EP2539439 - MODULATION OF ANGIOGENESIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.08.2019
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  14.09.2018
FormerGrant of patent is intended
Status updated on  07.09.2018
FormerExamination is in progress
Status updated on  13.07.2018
FormerGrant of patent is intended
Status updated on  11.03.2018
FormerExamination is in progress
Status updated on  23.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
ABT Holding Company
3201 Carnegie Avenue
Cleveland, OH 44115 / US
[2018/42]
Former [2013/01]For all designated states
ABT Holding Company
3210 Carnegie Avenue
Cleveland, OH 44115 / US
Inventor(s)01 / WODA, Juliana, Megan
3193 Onaway Road
Shaker Heights, OH 44120 / US
02 / TING, Anthony, E.
18019 Fernway Road
Shaker Heights, OH 44122 / US
03 / LEHMAN, Nicholas, A.
35510 Pettibone Road
Solon, OH 44139 / US
 [2013/01]
Representative(s)Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2018/42]
Former [2013/17]Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP 20 Red Lion Street London
WC1R 4PJ / GB
Former [2013/01]Hollywood, Jane Constance
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date11747958.423.02.2011
[2018/42]
WO2011US25846
Priority number, dateUS20100308103P25.02.2010         Original published format: US 308103 P
[2013/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011106365
Date:01.09.2011
Language:EN
[2011/35]
Type: A1 Application with search report 
No.:EP2539439
Date:02.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 01.09.2011 takes the place of the publication of the European patent application.
[2013/01]
Type: B1 Patent specification 
No.:EP2539439
Date:17.10.2018
Language:EN
[2018/42]
Search report(s)International search report - published on:US01.09.2011
(Supplementary) European search report - dispatched on:EP05.08.2013
ClassificationIPC:A61K35/545, G01N33/50, C12N5/074, A61K38/19, A61K38/20, A61P9/00
[2018/13]
CPC:
A61K35/545 (EP,IL,KR); C12N5/0696 (IL,KR); A61K35/00 (IL,KR);
A61K35/12 (IL,KR); A61P13/12 (EP,IL); A61P35/00 (EP,IL);
A61P9/00 (EP,IL); A61P9/04 (EP,IL); A61P9/08 (EP,IL);
A61P9/10 (EP,IL); A61P9/14 (EP,IL); C12N5/00 (IL,KR);
C12N5/0602 (IL,KR); C12N5/0634 (IL,KR); G01N33/5008 (EP,IL,KR);
C12N2501/02 (IL,KR); C12N2501/2301 (IL,KR); C12N2501/24 (IL,KR);
C12N2501/25 (IL,KR) (-)
Former IPC [2013/35]C12N5/074, A61P9/00, A61K38/19, A61K38/20
Former IPC [2013/01]C12N5/074, A61P9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANGIOGENESE-MODULATION[2013/01]
English:MODULATION OF ANGIOGENESIS[2013/01]
French:MODULATION DE L'ANGIOGENÈSE[2013/01]
Entry into regional phase19.09.2012National basic fee paid 
19.09.2012Search fee paid 
19.09.2012Designation fee(s) paid 
19.09.2012Examination fee paid 
Examination procedure19.09.2012Examination requested  [2013/01]
25.02.2014Amendment by applicant (claims and/or description)
15.10.2015Despatch of a communication from the examining division (Time limit: M04)
15.02.2016Reply to a communication from the examining division
13.07.2016Despatch of a communication from the examining division (Time limit: M06)
10.01.2017Reply to a communication from the examining division
22.02.2018Cancellation of oral proceeding that was planned for 19.03.2018
12.03.2018Communication of intention to grant the patent
19.03.2018Date of oral proceedings (cancelled)
10.07.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.07.2018Fee for grant paid
10.07.2018Fee for publishing/printing paid
06.09.2018Information about intention to grant a patent
06.09.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.10.2015
Opposition(s)18.07.2019No opposition filed within time limit [2019/39]
Fees paidRenewal fee
27.02.2013Renewal fee patent year 03
27.02.2014Renewal fee patent year 04
26.02.2015Renewal fee patent year 05
26.02.2016Renewal fee patent year 06
27.02.2017Renewal fee patent year 07
27.02.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.02.2011
AL17.10.2018
AT17.10.2018
CY17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
MK17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
MT23.02.2019
[2022/31]
Former [2021/33]HU23.02.2011
AL17.10.2018
AT17.10.2018
CY17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
MT23.02.2019
Former [2021/26]AL17.10.2018
AT17.10.2018
CY17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
MT23.02.2019
Former [2020/29]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
MT23.02.2019
Former [2020/17]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
Former [2019/50]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
Former [2019/47]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
LU23.02.2019
Former [2019/45]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/40]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/37]AL17.10.2018
AT17.10.2018
CZ17.10.2018
EE17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/35]AL17.10.2018
AT17.10.2018
CZ17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
RS17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/26]AL17.10.2018
AT17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
RS17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/25]AT17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
RS17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
Former [2019/24]AT17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
Former [2019/23]AT17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
PL17.10.2018
BG17.01.2019
NO17.01.2019
IS17.02.2019
Former [2019/22]FI17.10.2018
LT17.10.2018
PL17.10.2018
BG17.01.2019
NO17.01.2019
IS17.02.2019
Former [2019/21]FI17.10.2018
LT17.10.2018
NO17.01.2019
IS17.02.2019
Former [2019/20]LT17.10.2018
NO17.01.2019
Documents cited:Search[XY] US2008274088  (PANOSKALTSIS-MORTARI ANGELA et al.) [X] 1,10 * paragraphs 10-15, 20-21, 48, 57-63, 70E, example 1, claims *[Y] 1-10
 [XY] US2007253937  (YOON YOUNG-SUP et al.) [X] 1,10 * abstract, paras 1, 12-13, 33-42, claims 1-44 *[Y] 1-10
 [XY] US2005181502  (FURCHT LEO T et al.) [X] 1,10 * examples 1-2; pages 1-2, paragraphs 26-27, 84-127, claims *[Y] 1-10
 [Y] WO2004039248  (GEN HOSPITAL CORP et al.) [Y] 11 * claims 45, 49, page 22, para 2, page 38, lines 17-25, page 60, lines 5-13 *
 [Y] JP2005065661  
 [Y] US2006036086  (JAIN RAKESH K et al.) [Y] 11 * abstract *
 [Y]   DATABASE WPI Week 200523, Derwent World Patents Index; AN 2005-218303, XP002703633 [Y] 11 * abstract *
 [Y]   DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; September 2005 (2005-09-01), SALES KURT J ET AL: "A novel angiogenic role for prostaglandin F-2 alpha-FP receptor interaction in human endometrial adenocarcinomas", XP002703668, Database accession no. PREV200510294799 [Y] 11 * abstract *
 [Y]   SALES KURT J ET AL: "A novel angiogenic role for prostaglandin F-2 alpha-FP receptor interaction in human endometrial adenocarcinomas", CANCER RESEARCH, vol. 65, no. 17, September 2005 (2005-09-01), pages 7707 - 7716, ISSN: 0008-5472
ExaminationWO2008148105
   LEI Y ET AL: "THERAPEUTIC ANGIOGENESIS. DEVISING NEW STRATEGIES BASED ON PAST EXPERIENCE", BASIC RESEARCH IN CARDIOLOGY, STEINKOPFF, DARMSTADT, DE, vol. 99, no. 2, 1 January 2004 (2004-01-01), pages 121 - 132, XP008065176, ISSN: 0300-8428, DOI: 10.1007/S00395-004-0447-X [Y] 1-10

DOI:   http://dx.doi.org/10.1007/s00395-004-0447-x
by applicant  SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual, 3rd ed.,", 2001, COLD SPRING HARBOR LABORATORY PRESS
   AUSUBEL ET AL.: "Current Protocols in Molecular Biology", 1992, GREENE PUBLISHING ASSOCIATES
   HARLOW; LANE: "Antibodies: A Laboratory Manual", 1990, COLD SPRING HARBOR LABORATORY PRESS
   YAMANAKA, S. ET AL., CELL STEM CELL, vol. 1, 2007, pages 39 - 49
   WERNIG ET AL., PNAS, vol. 105, 2008, pages 5856 - 5861
   JAENISCH ET AL., CELL, vol. 132, 2008, pages 567 - 582
   HANNA ET AL., CELL, vol. 133, 2008, pages 250 - 264
   BRAMBRINK ET AL., CELL STEM CELL, vol. 2, 2008, pages 151 - 159
   VERFAILLIE, C.M., TRENDS CELL BIOL, vol. 12, 2002, pages 502 - 8
   JAHAGIRDAR, B.N. ET AL., EXP HEMATOL, vol. 29, 2001, pages 543 - 56
   REYES, M.; C.M. VERFAILLIE, ANN N YACAD SCI, vol. 938, 2001, pages 231 - 233
   JIANG, Y. ET AL., EXP HEMATOL, 2002, pages 30896 - 904
   JIANG, Y. ET AL., NATURE, vol. 418, 2002, pages 41 - 9
   WILMUT ET AL., NATURE, vol. 385, 1997, pages 810 - 813
   YING ET AL., NATURE, vol. 416, 2002, pages 545 - 548
   GUAN ET AL., NATURE, vol. 440, 2006, pages 1199 - 1203
   TAKAHASHI ET AL., CELL, vol. 126, 2006, pages 663 - 676
   OKITA ET AL., NATURE, vol. 448, 2007, pages 313 - 317
   TAKAHASHI ET AL., CELL, vol. 131, 2007, pages 861 - 872
   HOCHEDLINGER; JAENISCH, NATURE, vol. 441, 2006, pages 1061 - 1067
   YAMANAKA, S., CELL STEM CELL, vol. 1, 2007, pages 39 - 49
   SOLTER, D., NAT REV GENET, vol. 7, 2006, pages 319 - 327
   ZWAKA; THOMSON, DEVELOPMENT, vol. 132, 2005, pages 227 - 233
   TADA ET AL., CURR BIOL, vol. 11, 2001, pages 1553 - 1558
   COWAN ET AL., SCIENCE, vol. 309, 2005, pages 1369 - 1373
   YU ET AL., SCIENCE, vol. 318, 2006, pages 1917 - 1920
   DO; SCHOLER, STEM CELLS, vol. 22, 2004, pages 941 - 949
   SILVA ET AL., NATURE, vol. 441, 2006, pages 997 - 1001
   NARASIMHA ET AL., CURR BIOL, vol. 7, 1997, pages 881 - 884
   WAKAYAMA ET AL., STEM CELLS, vol. 25, 2007, pages 986 - 993
   EGGAN ET AL., NATURE, vol. 428, 2004, pages 44 - 49
   MATSUI ET AL., CELL, vol. 70, 1992, pages 841 - 847
   KANATSU-SHINOHARA ET AL., CELL, vol. 119, 2004, pages 1001 - 1012
   SEANDEL ET AL., NATURE, vol. 449, 2007, pages 346 - 350
   BRONS ET AL., NATURE, vol. 448, 2007, pages 191 - 195
   TESAR ET AL., NATURE, vol. 448, 2007, pages 196 - 199
   CIBELLI ET AL., SCIENCE, 2002, pages 295L819
   REVAZOVA ET AL., CLONING STEM CELLS, vol. 9, 2007, pages 432 - 449
   THOMSON ET AL., SCIENCE, vol. 282, 1998, pages 1145 - 1147
   JIANG ET AL., NATURE, vol. 418, 2002, pages 41 - 49
   PHINNEY; PROCKOP, STEM CELLS, vol. 25, 2007, pages 2896 - 2902
   VAN DE VEN ET AL., EXP HEMATOL, vol. 35, 2007, pages 1753 - 1765
   CLARKE ET AL., SCIENCE, vol. 288, 2000, pages 1660 - 1663
   TAKAHASHI; YAMANAKA, CELL, vol. 126, 2006, pages 663 - 676
   CHAMBERS; SMITH, ONCOGENE, vol. 23, 2004, pages 7150 - 7160
   IVANONA ET AL., NATURE, vol. 442, 2006, pages 5330538
   MASUI ET AL., NAT CELL BIOL, vol. 9, 2007, pages 625 - 635
   NAKAGAWA ET AL., NAT BIOTECHNOL, vol. 26, 2008, pages 191 - 106
   WERNING ET AL., NATURE, vol. 448, 2008, pages 318 - 324
   YU ET AL., SCIENCE, vol. 318, 2007, pages 1917 - 1920
   BREYER ET AL., EXPERIMENTAL HEMATOLOGY, vol. 34, 2006, pages 1596 - 1601
   SUBRAMANIAN ET AL.: "Methods in Molecular Biology", vol. 636, 2010, article "Cellular Programming and Reprogramming: Methods and Protocols", pages: 55 - 78
   V, SCHLOSSMAN, ET AL.: "Leukocyte Typing", 1995, OXFORD UNIVERSITY PRESS
   BASCH ET AL., IMMUNOAFFINITY CHROMATOGRAPHY, 1983
   WYSOCKI; SATO, FLUORESCENCE-ACTIVATED CELL SORTING, 1978
   OHASHI ET AL., NATURE MEDICINE, vol. 13, 2007, pages 880 - 885
   MATSUMOTO ET AL., J BIOSCIENCE AND BIOENGINEERING, vol. 105, 2008, pages 350 - 354
   KIROUAC ET AL., CELL STEM CELL, vol. 3, 2008, pages 369 - 381
   CHUA ET AL., BIOMATERIALS, vol. 26, 2005, pages 2537 - 2547
   DROBINSKAYA ET AL., STEM CELLS, vol. 26, 2008, pages 2245 - 2256
   DVIR-GINZBERG ET AL., FASEB J, vol. 22, 2008, pages 1440 - 1449
   TURNER ET AL., JBIOMED MATER RES PART B: APPL BIOMATER, vol. 82B, 2007, pages 156 - 168
   MIYAZAWA ET AL., JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 22, 2007, pages 1959 - 1964
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.